NASDAQ$SMLR
Semler Scientific Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Semler Scientific's Q1 2023 financial performance was marked by record quarterly revenues and pre-tax net income, driven predominately by sales of QuantaFlo for peripheral artery disease testing.
Semler Scientific reported a 30% increase in revenue, reaching $18.2 million, and a 48% increase in net income, amounting to $5.0 million for Q1 2023. The company's cash, cash equivalents, and short-term investments totaled $43.0 million.
- Revenue increased by 30% to $18.2 million compared to Q1 2022.
- Net income increased by 48% to $5.0 million compared to Q1 2022.
- Cash, cash equivalents, and short-term investments totaled $43.0 million.
- The company is focused on developing its business in heart dysfunction and diabetes.
Headline financials
Revenue & EPS history
Semler Scientific · Revenue · Quarterly
$18.2M
Forward guidance
Semler Scientific is focused on developing its business in two new disease areas, heart dysfunction and diabetes.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports
-0.2%
Avg return
Earnings day
-2.4%
Avg return
5 days after
-5.8%
Avg return
30 days after
54%
25 / 46 earnings
Positive
+33.6%
Q4 2014
Best reaction
-33.3%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | -10.7% | -16.0% | -25.1% | |
| Q2 2025 | -1.8% | +2.0% | -20.7% | |
| Q1 2025 | -11.4% | +17.9% | -19.3% | |
| Q4 2024 | +3.0% | -12.4% | -22.7% | |
| Q3 2024 | +27.1% | +29.9% | +106.6% | |
| Q2 2024 | -5.4% | -1.7% | -16.7% | |
| Q4 2023 | -32.7% | -36.8% | -42.5% | |
| Q3 2023 | +7.6% | — | — | |
| Q2 2023 | +7.9% | — | — | |
| Q1 2023 | +13.8% | — | — | |
| Q4 2022 | +26.9% | — | — | |
| Q3 2022 | -33.3% | — | — | |
| Q2 2022 | +19.4% | — | — | |
| Q1 2022 | -20.6% | — | — | |
| Q4 2021 | -27.3% | — | — | |
| Q3 2021 | -25.6% | — | — | |
| Q2 2021 | -2.7% | — | — | |
| Q1 2021 | +1.5% | — | — | |
| Q4 2020 | +13.6% | — | — | |
| Q3 2020 | +10.0% | — | — | |
| Q2 2020 | -3.6% | — | — | |
| Q1 2020 | -2.6% | — | — | |
| Q4 2019 | +1.8% | — | — | |
| Q3 2019 | +1.7% | — | — | |
| Q2 2019 | +1.5% | — | — | |
| Q1 2019 | -2.7% | — | — | |
| Q4 2018 | +4.8% | — | — | |
| Q3 2018 | -12.5% | — | — | |
| Q2 2018 | +20.6% | — | — | |
| Q1 2018 | +6.4% | — | — | |
| Q4 2017 | +2.5% | — | — | |
| Q3 2017 | +16.0% | — | — | |
| Q2 2017 | -5.9% | — | — | |
| Q1 2017 | +1.5% | — | — | |
| Q4 2016 | +7.9% | — | — | |
| Q3 2016 | -16.0% | — | — | |
| Q2 2016 | +8.1% | — | — | |
| Q1 2016 | -9.2% | — | — | |
| Q4 2015 | -7.9% | — | — | |
| Q3 2015 | +0.1% | — | — | |
| Q2 2015 | -12.2% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2014 | +33.6% | — | — | |
| Q3 2014 | -3.7% | — | — | |
| Q2 2014 | -2.0% | — | — | |
| Q1 2014 | +1.2% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro